Cargando…

Deep analysis of acquired resistance to FGFR1 inhibitor identifies MET and AKT activation and an expansion of AKT1 mutant cells

The development of acquired resistance (AR) to tyrosine kinase inhibitors (TKIs) of FGFR1 activation is currently not well understood. To gain a deeper insight into this matter in lung cancer, we used the FGFR1-amplified DMS114 cell line and generated multiple clones with AR to an FGFR1-TKI. We mole...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gimenez-Xavier, Pol, Pros, Eva, Aza, Ana, Moran, Sebastian, Tonda, Raul, Esteve-Codina, Anna, Dabad, Marc, Sanchez-Cespedes, Montse
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101141/ https://www.ncbi.nlm.nih.gov/pubmed/30140389 http://dx.doi.org/10.18632/oncotarget.25862

Ejemplares similares

FGFR1 Induces Acquired Resistance Against Gefitinib By Activating AKT/mTOR Pathway In NSCLC
por: Zhang, Dan, et al.
Publicado: (2019)

Combined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cells
por: Terp, Mikkel G., et al.
Publicado: (2021)

MiR‐3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway
por: Kong, Shiqi, et al.
Publicado: (2020)

MET-Pyk2 Axis Mediates Acquired Resistance to FGFR Inhibition in Cancer Cells
por: Kitowska, Kamila, et al.
Publicado: (2021)

B2M, JAK2 and MET in the genetic landscape of immunotolerance in lung cancer
por: Sanchez-Cespedes, Montse
Publicado: (2018)

Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy
por: Kim, S-M, et al.
Publicado: (2016)

MET and AKT Genetic Influence on Facial Emotion Perception
por: Lin, Ming-Teng, et al.
Publicado: (2012)

AKT-ions with a TWIST between EMT and MET
por: Tang, Huifang, et al.
Publicado: (2016)

An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness
por: Quan, Mei-Yu, et al.
Publicado: (2020)

Co-dependency for MET and FGFR1 in basal triple-negative breast cancers
por: Sung, Vanessa Y. C., et al.
Publicado: (2021)

Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer
por: Elakad, Omar, et al.
Publicado: (2022)

Dual inhibition of Akt and c‐Met as a second‐line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells
por: Han, Peng, et al.
Publicado: (2017)

Corrigendum: An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness
por: Quan, Mei-Yu, et al.
Publicado: (2020)

MicroRNA-761 targets FGFR1 to suppress the malignancy of osteosarcoma by deactivating PI3K/Akt pathway
por: Lv, Zhongzhe, et al.
Publicado: (2019)

Acquired resistance to BRAF inhibition induces epithelial-to-mesenchymal transition in BRAF (V600E) mutant thyroid cancer by c-Met-mediated AKT activation
por: Byeon, Hyung Kwon, et al.
Publicado: (2016)

FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR
por: Li, Lei, et al.
Publicado: (2019)

PRMT5/FGFR3/AKT Signaling Axis Facilitates Lung Cancer Cell Metastasis
por: Zheng, Yonghua, et al.
Publicado: (2023)

Ovarian Fragmentation and AKT Stimulation for Expansion of Fertile Lifespan
por: Vo, Kim Cat Tuyen, et al.
Publicado: (2021)

MicroRNA-761 Targets FGFR1 to Suppress the Malignancy of Osteosarcoma by Deactivating PI3K/Akt Pathway [Retraction]
Publicado: (2021)

MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer
por: Alburquerque-Bejar, Juan J., et al.
Publicado: (2023)

Inhibition of MEIS3 Generates Cetuximab Resistance through c-Met and Akt
por: Cai, Ping, et al.
Publicado: (2020)

MET∆14 promotes a ligand-dependent, AKT-driven invasive growth
por: Cerqua, Marina, et al.
Publicado: (2022)

Long Noncoding RNA FGFR3-AS1 Promotes Hepatocellular Carcinoma Carcinogenesis via Modulating the PI3K/AKT Pathway
por: Zhuang, Juhua, et al.
Publicado: (2018)

FGF10 mitigates doxorubicin-induced myocardial toxicity in mice via activation of FGFR2b/PHLDA1/AKT axis
por: Zhou, De-pu, et al.
Publicado: (2023)

In-vitro and in-vivo combined effect of ARQ 092, an AKT inhibitor, with ARQ 087, a FGFR inhibitor
por: Yu, Yi, et al.
Publicado: (2017)

FGFR(3S249C) mutation promotes chemoresistance by activating Akt signaling in bladder cancer cells
por: Xie, Xina, et al.
Publicado: (2019)

FGF1 protects FGFR1-overexpressing cancer cells against drugs targeting tubulin polymerization by activating AKT via two independent mechanisms
por: Szymczyk, Jakub, et al.
Publicado: (2022)

Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer
por: Jacobsen, Kirstine, et al.
Publicado: (2017)

All Akt Isoforms (Akt1, Akt2, Akt3) Are Involved in Normal Hearing, but Only Akt2 and Akt3 Are Involved in Auditory Hair Cell Survival in the Mammalian Inner Ear
por: Brand, Yves, et al.
Publicado: (2015)

Compensatory growth in novel Drosophila Akt1 mutants
por: Slade, Jennifer D, et al.
Publicado: (2015)

Decrotonylation of AKT1 promotes AKT1 phosphorylation and activation during myogenic differentiation
por: Qian, Zhengyu, et al.
Publicado: (2022)

Brown fat organogenesis and maintenance requires AKT1 and AKT2
por: Sanchez-Gurmaches, Joan, et al.
Publicado: (2019)

FOXM1 confers resistance to gefitinib in lung adenocarcinoma via a MET/AKT-dependent positive feedback loop
por: Wang, Yu, et al.
Publicado: (2016)

Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients
por: Le Page, C, et al.
Publicado: (2006)

The AKT-independent MET–V-ATPase–MTOR axis suppresses liver cancer vaccination
por: Huang, Xing, et al.
Publicado: (2020)

Mahuang Decoction Attenuates Airway Inflammation and Remodeling in Asthma via Suppression of the SP1/FGFR3/PI3K/AKT Axis
por: Wei, Lina, et al.
Publicado: (2022)

CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities
por: Terry, Stéphane, et al.
Publicado: (2015)

Akt methylation by SETDB1 promotes Akt kinase activity and oncogenic functions
por: Guo, Jianping, et al.
Publicado: (2019)

Identification of P-Rex1 in the Regulation of Liver Cancer Cell Proliferation and Migration via HGF/c-Met/Akt Pathway
por: Qiu, Wancheng, et al.
Publicado: (2020)

MACC1 regulates PDL1 expression and tumor immunity through the c‐Met/AKT/mTOR pathway in gastric cancer cells
por: Tong, Gangling, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r7cj87ee2n37a54nasvgr2m6c9